A Healthy Volunteer Study to Compare Fezagepras (PBI-4050) With Sodium Phenylbutyrate

NCT05349435 · clinicaltrials.gov ↗
PHASE1
Phase
TERMINATED
Status
8
Enrollment
INDUSTRY
Sponsor class

Stopped Sponsor has decided to discontinue development of fezegepras based on initial pharmacokinetic results

Conditions

Interventions

Sponsor

Liminal BioSciences Ltd.